Month 5 & Beyond : Reach the maintenance dose of 2.5 mg weekly, subject to your healthcare providers approval and your treatment response
The results of the placebo sensitivity analysis were to be expected, because the majority of subjects receiving comparators (59%) were randomized to placebo rather than active comparators in the included trials
Additionally, both ADA/EASD and AACE guidelines stress the importance of treating cardiovascular risk factors
Cost Although tablets could be less expensive, their worth is debatable without demonstrated effectiveness
Lp li liu dng 900 mg - 1200 mg sau iu tr ngy th 2 v ngy th 5
^In a multi-national, double-blind clinical trial of over 17,000 patients with BMI of 27 or greater, weekly injections of semaglutide for a mean duration of 33 months reduced the risk of a composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke by 20%